# Daniel G. Bichet

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniel-g-bichet/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,255 |
| Field | Electrolyte and hormonal disorders |
| h-index | 73 |
| i10-index | 198 |
| Last Known Institution | Hôpital du Sacré-Cœur de Montréal |
| OpenAlex ID | https://openalex.org/A5082014716 |
| ORCID iD | 0000-0003-2856-6850 |
| Works | 399 |

## Researcher papers

Showing 12 of 16.

- [Clinical practice guideline on diagnosis and treatment of hyponatraemia](https://scholariq.org/papers/clinical-practice-guideline-on-diagnosis-and-treatment-of-hyponatraemia/)
- [Clinical practice guideline on diagnosis and treatment of hyponatraemia](https://scholariq.org/papers/clinical-practice-guideline-on-diagnosis-and-treatment-of-hyponatraemia-3/)
- [A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation](https://scholariq.org/papers/a-peptide-derived-from-a-2-adrenergic-receptor-transmembrane-domain-inhibits/)
- [Clinical practice guideline on diagnosis and treatment of hyponatraemia](https://scholariq.org/papers/clinical-practice-guideline-on-diagnosis-and-treatment-of-hyponatraemia-2/)
- [Agalsidase-Beta Therapy for Advanced Fabry Disease](https://scholariq.org/papers/agalsidase-beta-therapy-for-advanced-fabry-disease/)
- [Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants](https://scholariq.org/papers/pharmacological-chaperones-rescue-cell-surface-expression-and-function-of/)
- [Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat](https://scholariq.org/papers/treatment-of-fabry-s-disease-with-the-pharmacologic-chaperone-migalastat/)
- [Nephrogenic Diabetes Insipidus](https://scholariq.org/papers/nephrogenic-diabetes-insipidus/)
- [Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study](https://scholariq.org/papers/oral-pharmacological-chaperone-migalastat-compared-with-enzyme-replacement/)
- [Radioimmunoassay of Plasma Arginine Vasopressin in Hyponatremic Patients with Congestive Heart Failure](https://scholariq.org/papers/radioimmunoassay-of-plasma-arginine-vasopressin-in-hyponatremic-patients-with/)
- [Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia](https://scholariq.org/papers/oral-tolvaptan-is-safe-and-effective-in-chronic-hyponatremia/)
- [Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/updated-canadian-expert-consensus-on-assessing-risk-of-disease-progression-and/)

## Researcher topics

- [Electrolyte and hormonal disorders](https://scholariq.org/topics/electrolyte-and-hormonal-disorders/)
- [Ion Transport and Channel Regulation](https://scholariq.org/topics/ion-transport-and-channel-regulation/)
- [Lysosomal Storage Disorders Research](https://scholariq.org/topics/lysosomal-storage-disorders-research/)
- [Neuroendocrine regulation and behavior](https://scholariq.org/topics/neuroendocrine-regulation-and-behavior/)
- [Biomedical Research and Pathophysiology](https://scholariq.org/topics/biomedical-research-and-pathophysiology/)

## Researcher university

- [Hôpital du Sacré-Cœur de Montréal](https://scholariq.org/institutions/hopital-du-sacre-c-ur-de-montreal/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.